上颌窦底提升中骨增量材料的专家共识:生物活性制剂、细胞疗法与不植入骨增量材料的上颌窦底提升  

Expert consensus on bone grafting materials for sinus floor elevation: bioactive agents, cell therapies and graft-free sinus floor elevation

作　　者：中华口腔医学会口腔种植专业委员会 吴轶群[2] 宿玉成 王宁涛[4] 王凤[4] Chinese Society of Oral Implantology;Wu Yiqun;Su Yucheng;Wang Ningtao;Wang Feng(不详;Second Dental Center,Shanghai Ninth People’s Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 201999,China;Dental Implant Center,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Beijing 100032,China;Shanghai Ninth People’s Hospital,Shanghai Jiao Tong University School of Medicine)

机构地区：[1]不详 [2]上海交通大学医学院附属第九人民医院口腔第二门诊部,201999 [3]中国医学科学院北京协和医院口腔种植中心,100032 [4]上海交通大学医学院附属第九人民医院

出　　处：《中国口腔种植学杂志》2022年第6期329-333,共5页Chinese Journal of Oral Implantology

摘　　要：上颌窦底提升是解决上颌后牙区垂直向骨量不足的可靠方法。目前应用于上颌窦底骨增量的材料较多,关于材料的选择尚无统一共识。本文基于现有临床文献证据,针对生物活性制剂、细胞疗法以及不植入骨增量材料的上颌窦底提升进行总结及阐述,以期为临床上颌窦底提升中骨增量材料的选择提供参考。Sinus floor elevation is a reliable approach to solve the problem of vertical bone deficiency in the posterior maxillary area. At present, there are many bone grafting materials available for sinus floor elevation, but no consensus on their selection is achieved. This consensus focuses on bioactive agents, cell therapies and graft-free sinus floor elevation, and summarizes the results on their clinical application, hoping to provide a reference for the selection during clinical practice.

关 键 词：上颌窦底提升 骨增量材料 骨形态发生蛋白 自体血小板浓缩制品 干细胞 不植入骨增量材料的上颌窦底提升 专家共识 

分 类 号：R78[医药卫生—口腔医学]